How Jonas Salk and Albert Sabin pioneered double-blind methodology, HeLa cell assays, and IBM data processing – innovations that became the global standard for clinical trials.
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Patient-Centricity Is In Everything We Do: Designing Accessible eClinical Technology
By prioritizing patient centricity within an eClinical platform’s design, sponsors can tailor patient engagement to achieve outcomes based on a study’s indication, patient population, and end goals.
-
Ready For Remote: eCOA Adapts To A Hybrid World
Due to the global health impact of COVID-19, many aspects of daily life have been moved to a hybrid model, meaning a mix of in-person and technology-enabled interactions In this blog, learn why eCOAs are especially well-suited for hybrid clinical trials.
-
Navigating The Next Wave Of Innovation In eCOA
Learn how the right eCOA system enables site efficiency and elevated data quality, ensuring trials run smoothly and deliver more reliable results.
-
We Need Regulatory Clarity—Not Complexity In Clinical Trial Technology
The current U.S. deregulatory momentum should not diminish compliance standards but instead serve as a call to streamline and modernize regulatory guidance.
-
Data Quality And How It Impacts Clinical Trials
Explore a shared platform that helps organizations overcome technical burdens, reduce expenditures, and accelerate the delivery of innovative therapies.
-
RTSM: Randomization And Cohort Management, IP Inventory Management
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Deconstructing Central Rating In Clinical Trials
Analyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this
-
Choosing The Right eClinRO Solution For Reliable Trial Data
Electronic clinician-reported outcomes (eClinROs) enhance the quality and consistency of clinical trial data. Discover key factors to consider when selecting an eClinRO provider.
-
Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?
Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.
-
Real-World Data Capture With EDC
This case study explores how a Ph.D. candidate partnered with Castor to develop software that seamlessly moves RWD between hospital systems and Castor’s EDC.
FROM THE EDITOR
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
- The Dream Is EHR-To-EDC — eSource Is The Wake-Up Call
- Synthetic Control Arms: When Data Stands In For Patients
- Paving The Way For Sites To Use Their Own Tech
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
- 01.22.26 -- The Role Of Open Source In Powering CDISC 360i